Ya-yong Zhang MD , Sen Yang MS , Lei Pu MD , Xu Qian MD , Le Ren MS , Yong-bo Li MS , Yan Liu BN , Chao-liang Nian MS , Hao-jiang Liu MS , Ze Yang MS , Ying-ming Li MS , Jian-feng Liu MS , Yun-feng Zi MD , Ya-Xiong Li BM
{"title":"新改良cabrol术加cabrol-瘘治疗469例低冠状动脉口主动脉根动脉瘤的安全性和有效性","authors":"Ya-yong Zhang MD , Sen Yang MS , Lei Pu MD , Xu Qian MD , Le Ren MS , Yong-bo Li MS , Yan Liu BN , Chao-liang Nian MS , Hao-jiang Liu MS , Ze Yang MS , Ying-ming Li MS , Jian-feng Liu MS , Yun-feng Zi MD , Ya-Xiong Li BM","doi":"10.1016/j.xjtc.2025.04.028","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>The study objectives were to evaluate the clinical efficacy, safety, and applicability of the neo-modified Cabrol procedure.</div></div><div><h3>Methods</h3><div>This study uses a retrospective cohort design of 469 patients who underwent the neo-modified Cabrol procedure between December 2012 and June 2023. Cross-sectional follow-up was performed between September 2023 and February 2024. The fate of the coronary interposition graft was evaluated by reviewing the data and images from computed tomography angiography of the aorta and coronary arteries of the follow-up patients.</div></div><div><h3>Results</h3><div>A total of 469 patients (mean age 53.7 ± 10.7 years; 409 male and 60 female patients) were included. The mean follow-up was 3.14 years (range, 0.00-9.95 years) for a total of 1472.84 patient-years. All-cause mortality rate within 30 days was 2.6% (n = 12). Outpatient/telephone/WeChat follow-up was completed by 100% of discharged patients (n = 457). Actuarial survivals were 95.9% ± 0.1%, 89.4% ± 0.2%, and 78.1% ± 0.6% at 1, 5, and 10 years, respectively. There were no neo-modified Cabrol procedure interposition graft–related complications, such as coronary fistula, pseudoaneurysm, graft twisting, stenosis, occlusion, or thrombosis.</div></div><div><h3>Conclusions</h3><div>The neo-modified Cabrol procedure is a safe and effective approach, offering favorable perioperative outcomes and long-term graft patency. Multicenter randomized controlled trials are needed to comprehensively evaluate the effectiveness of this technique.</div></div>","PeriodicalId":53413,"journal":{"name":"JTCVS Techniques","volume":"32 ","pages":"Pages 20-34"},"PeriodicalIF":1.9000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety and efficacy of the neo-modified cabrol procedure with cabrol-fistula in 469 patients with low coronary ostia aortic root aneurysm\",\"authors\":\"Ya-yong Zhang MD , Sen Yang MS , Lei Pu MD , Xu Qian MD , Le Ren MS , Yong-bo Li MS , Yan Liu BN , Chao-liang Nian MS , Hao-jiang Liu MS , Ze Yang MS , Ying-ming Li MS , Jian-feng Liu MS , Yun-feng Zi MD , Ya-Xiong Li BM\",\"doi\":\"10.1016/j.xjtc.2025.04.028\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>The study objectives were to evaluate the clinical efficacy, safety, and applicability of the neo-modified Cabrol procedure.</div></div><div><h3>Methods</h3><div>This study uses a retrospective cohort design of 469 patients who underwent the neo-modified Cabrol procedure between December 2012 and June 2023. Cross-sectional follow-up was performed between September 2023 and February 2024. The fate of the coronary interposition graft was evaluated by reviewing the data and images from computed tomography angiography of the aorta and coronary arteries of the follow-up patients.</div></div><div><h3>Results</h3><div>A total of 469 patients (mean age 53.7 ± 10.7 years; 409 male and 60 female patients) were included. The mean follow-up was 3.14 years (range, 0.00-9.95 years) for a total of 1472.84 patient-years. All-cause mortality rate within 30 days was 2.6% (n = 12). Outpatient/telephone/WeChat follow-up was completed by 100% of discharged patients (n = 457). Actuarial survivals were 95.9% ± 0.1%, 89.4% ± 0.2%, and 78.1% ± 0.6% at 1, 5, and 10 years, respectively. There were no neo-modified Cabrol procedure interposition graft–related complications, such as coronary fistula, pseudoaneurysm, graft twisting, stenosis, occlusion, or thrombosis.</div></div><div><h3>Conclusions</h3><div>The neo-modified Cabrol procedure is a safe and effective approach, offering favorable perioperative outcomes and long-term graft patency. Multicenter randomized controlled trials are needed to comprehensively evaluate the effectiveness of this technique.</div></div>\",\"PeriodicalId\":53413,\"journal\":{\"name\":\"JTCVS Techniques\",\"volume\":\"32 \",\"pages\":\"Pages 20-34\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JTCVS Techniques\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666250725001750\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JTCVS Techniques","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666250725001750","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Safety and efficacy of the neo-modified cabrol procedure with cabrol-fistula in 469 patients with low coronary ostia aortic root aneurysm
Objectives
The study objectives were to evaluate the clinical efficacy, safety, and applicability of the neo-modified Cabrol procedure.
Methods
This study uses a retrospective cohort design of 469 patients who underwent the neo-modified Cabrol procedure between December 2012 and June 2023. Cross-sectional follow-up was performed between September 2023 and February 2024. The fate of the coronary interposition graft was evaluated by reviewing the data and images from computed tomography angiography of the aorta and coronary arteries of the follow-up patients.
Results
A total of 469 patients (mean age 53.7 ± 10.7 years; 409 male and 60 female patients) were included. The mean follow-up was 3.14 years (range, 0.00-9.95 years) for a total of 1472.84 patient-years. All-cause mortality rate within 30 days was 2.6% (n = 12). Outpatient/telephone/WeChat follow-up was completed by 100% of discharged patients (n = 457). Actuarial survivals were 95.9% ± 0.1%, 89.4% ± 0.2%, and 78.1% ± 0.6% at 1, 5, and 10 years, respectively. There were no neo-modified Cabrol procedure interposition graft–related complications, such as coronary fistula, pseudoaneurysm, graft twisting, stenosis, occlusion, or thrombosis.
Conclusions
The neo-modified Cabrol procedure is a safe and effective approach, offering favorable perioperative outcomes and long-term graft patency. Multicenter randomized controlled trials are needed to comprehensively evaluate the effectiveness of this technique.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
